Abstract:Zi-Xuan Cheng, 1 Jian-Lan Hua, 1 Zhi-Jun Jie, 2 Xing-Jing Li, 3 Jing Zhang 1 1 Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, People's Republic of China; 3 Department of Respiratory Medicine, Zhongshan Hospital Wusong Branch, Fudan University, Shanghai, People's Republic of China Correspondence: Jing Zhang, Email Background: Chronic obstructive pulmonary disease (COPD) is a respiratory disorder with a complex etiology involving genetic and environmental factors. The dysbiosis of gut microbiota has been implicated in COPD. Mendelian Randomization (MR) provides a tool to investigate causal links using genetic variants as instrumental variables. This study aims to employ MR analysis to explore the causal relationship between gut microbiota, lung function, and COPD. Methods: We utilized genome-wide association study (GWAS) data from MiBioGen, UK Biobank and FinnGen, which were related to gut microbial taxa, lung function parameters including forced vital capacity in one second (FEV 1 ), forced vital capacity (FVC), and percentage of predicted FEV 1 (FEV 1 %pred), as well as GWAS data for COPD. MR analysis was conducted to assess the causal effects of gut microbiota on lung function and the risk of COPD. Sensitivity analysis was utilized to examine the stability of the causal relationships. Multiple testing and reverse analysis were employed to evaluate the robustness of these relationships. Results: Using the IVW method, 64 causal correlations were identified. Through conducting sensitivity analysis, multiple testing, and reverse analysis, we identified 14 robust and stable causal relationships. The bacterial taxa that showed a positive association with lung function included Desulfovibrionaceae , Erysipelotrichales, Desulfovibrionales, Clostridiales, Clostridia, Deltaproteobacteria and Erysipelotrichia , while Selenomonadales and Negativicutes showed a negative association with lung function. The abundance of Holdemanella were positively correlated with the risk of COPD, while FamilyXIII exhibited a negative correlation with the risk of COPD. Conclusion: Several microbial taxa were discovered to have a positive causal correlation with lung function, offering potential insights into the development of probiotics. The presence of microbial taxa negatively correlated with lung function and positively correlated with COPD emphasized the potential impact of gut microbiota dysbiosis on respiratory health. Keywords: COPD, lung function, gut-lung axis, gut microbiota, Mendelian randomization analysis Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disorder characterized by progressive airflow limitation and persistent respiratory symptoms. It presents a substantial global health burden and is a leading cause of morbidity and mortality. 1 The development of COPD involves a complex interplay between genetic factors, such as predisposition, and environmental factors, including smoking, air pollution, and respiratory infections. Despite the diverse causes of COPD, current diagnostic and therapeutic approaches are limited, highlighting the need for a deeper understanding of its underlying mechanisms. 2 In recent years, there has been growing interest in the role of the gut microbiota, which has been found to influence various aspects of human health, including immune regulation and systemic inflammation. 3 Accumulating evidence suggests a potential link between the dysbiosis of the gut microbiota and the development of COPD. 4,5 Observational studies have identified gut microbiome dysbiosis in COPD patients, and rodent models have demonstrated its contribution to COPD development. 6,7 Furthermore, there have been reports on the associations between gut microbial dysbiosis and a decline in lung function in individuals with COPD. 8–10 However, establishing a causal relationship between the gut microbiota and COPD remains challenging. The dynamic nature of the gut microbiome introduces challenges when attempting to characterize it through a single cross-sectional study design. 11 This is due to the potential variability in microbial sequencing results, which can be influenced by various confounders and covariates. It is crucial to acknowledge that factors such as the use of inhalers, particularly inhaled corticosteroids (ICS), and antibiotics can act as confoundi -Abstract Truncated-

Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases

Genetic evidence of bidirectional mendelian randomization study on the causality between gut microbiome and respiratory diseases contributes to gut-lung axis

Unveiling genetic links between gut microbiota and asthma: a Mendelian randomization

The associations between gut microbiota and chronic respiratory diseases: a Mendelian randomization study

Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study

Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study

Gut microbiota and risk of lower respiratory tract infections: a bidirectional two-sample Mendelian randomization study

Genetic Insights into the Gut-Lung Axis: Mendelian Randomization Analysis on Gut Microbiota, Lung Function, and COPD

Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study

Genetic evidence on the causality between gut microbiota and various asthma phenotypes: a two-sample Mendelian randomization study

Causal associations of gut microbiota and pulmonary tuberculosis: a two-sample Mendelian randomization study

A Bidirectional Mendelian Randomization reveals the association between the abundance of Gut Microbiota and multiple subtypes of Lung Cancer

P1.10-03 Gut Microbiota and Lung Cancer: A Mendelian Randomisation Study

Association of the gut microbiome and different phenotypes of COPD and asthma: a bidirectional Mendelian randomization study

Causal Relationship Between Gut Microbiota and Chronic Obstructive Pulmonary Disease: A Bidirectional Two-Sample Mendelian Randomization Study

Assessing causal relationships between gut microbiota and asthma: evidence from two sample Mendelian randomization analysis

Genetic and observational associations of lung function with gastrointestinal tract diseases: pleiotropic and mendelian randomization analysis

Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

Gut Microbiota and Respiratory Infections: Insights from Mendelian Randomization

Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study